[Clinical use of hematopoietic growth factors (hematopoietins)].
Ribas-Mundó
M
M
Departamento de Medicina, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona.
Ribas Bruguera
A
A
Gale
R P
RP
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D004921:Erythropoietin / Q000378:metabolism / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D009503:Neutropenia / Q000139:chemically induced / Q000209:etiology / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D015215:Zidovudine / Q000009:adverse effects
D003115:Colony-Stimulating Factors; D016298:Hematopoietic Cell Growth Factors; D014409:Tumor Necrosis Factor-alpha; D004921:Erythropoietin; D015215:Zidovudine
Uso clínico de los factores de crecimiento hematopoyéticos (hematopoyetinas).